Related Experiment Video
Updated: Jun 25, 2025

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
Platelet-rich plasma therapy for postoperative esophageal fistula in a pediatric patient
Marco Di Mitri1, Greta Chiastra1, Edoardo Collautti1
1Pediatric Surgery Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna 40138, Italy.
Insights
Platelet-rich plasma (PRP) effectively closed a persistent infant esophago-cutaneous fistula after surgery. This promising treatment offers hope for similar pediatric complications, reducing hospital stays and improving outcomes.
Area of Science:
- Pediatric Surgery
- Regenerative Medicine
- Wound Healing
Background:
- Esophago-cutaneous fistulas are challenging postoperative complications in pediatric patients, often leading to prolonged hospital stays and increased morbidity.
- Current management strategies for these fistulas can be difficult and may not always yield optimal results.
- Platelet-rich plasma (PRP) is being explored as a potential adjunctive therapy for various medical conditions due to its healing properties.
Observation:
- A 7-month-old infant developed a refractory esophago-cutaneous fistula post-esophagocoloplasty for esophageal atresia type A.
- Initial conservative management failed to close the fistula.
- PRP gel, derived from umbilical cord blood, was applied topically to the fistula site.
Findings:
- Complete closure of the esophago-cutaneous fistula was achieved after four applications of PRP gel.
- The treatment resulted in both functional recovery and satisfactory aesthetic outcomes for the patient.
- This case demonstrates the successful use of PRP in managing a complex pediatric surgical complication.
Implications:
- PRP shows significant potential as an effective adjunctive treatment for refractory postoperative esophago-cutaneous fistulas in pediatric patients.
- Further research is warranted to establish standardized protocols and confirm the efficacy of PRP for these specific complications.
- This approach may lead to reduced hospitalization duration and improved patient outcomes in pediatric surgical care.
Abstract:
Postoperative management of esophagocutaneous fistulas in pediatric patients is challenging, often resulting in prolonged hospitalization and increased morbidity. Platelet-rich plasma (PRP) has emerged as a promising adjunctive treatment for such complications. We present the case of a 7-month-old infant who developed an esophago-cutaneous fistula following esophagocoloplasty for esophageal atresia type A. Despite initial conservative management, the fistula persisted, prompting the application of PRP gel derived from umbilical cord blood. After four applications of PRP, complete closure of the fistula was achieved, leading to both functional and aesthetic results. This case highlights the potential of PRP in managing refractory postoperative esophageal fistulas in pediatric patients and underscores the need for further research to optimize treatment protocols and validate its efficacy for this sort of complications.
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:

